loading
Precedente Chiudi:
$1.66
Aprire:
$1.66
Volume 24 ore:
675.81K
Relative Volume:
0.34
Capitalizzazione di mercato:
$84.23M
Reddito:
-
Utile/perdita netta:
$-67.68M
Rapporto P/E:
-1.00
EPS:
-1.66
Flusso di cassa netto:
$-54.24M
1 W Prestazione:
-0.60%
1M Prestazione:
-6.21%
6M Prestazione:
-33.60%
1 anno Prestazione:
-75.41%
Intervallo 1D:
Value
$1.625
$1.71
Intervallo di 1 settimana:
Value
$1.58
$1.73
Portata 52W:
Value
$0.9857
$7.27

Cabaletta Bio Inc Stock (CABA) Company Profile

Name
Nome
Cabaletta Bio Inc
Name
Telefono
(267) 759-3100
Name
Indirizzo
2929 ARCH STREET, PHILADELPHIA, PA
Name
Dipendente
163
Name
Cinguettio
@CabalettaBio
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
CABA's Discussions on Twitter

Confronta CABA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CABA
Cabaletta Bio Inc
1.66 149.31M 0 -67.68M -54.24M -1.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-20 Downgrade Evercore ISI Outperform → In-line
2024-12-19 Downgrade Wells Fargo Overweight → Equal Weight
2024-10-10 Iniziato UBS Buy
2024-02-05 Iniziato Jefferies Buy
2023-11-29 Iniziato William Blair Outperform
2023-10-24 Iniziato Cantor Fitzgerald Overweight
2023-10-19 Iniziato Stifel Buy
2023-09-05 Iniziato Citigroup Buy
2023-07-18 Iniziato Guggenheim Buy
2023-01-27 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2022-08-30 Downgrade Morgan Stanley Overweight → Equal-Weight
2021-12-08 Iniziato Wells Fargo Overweight
2021-10-19 Ripresa Morgan Stanley Overweight
2021-06-30 Iniziato Mizuho Buy
2021-01-08 Iniziato Chardan Capital Markets Buy
2020-10-13 Iniziato H.C. Wainwright Buy
2019-11-19 Iniziato Cowen Outperform
2019-11-19 Iniziato Evercore ISI Outperform
2019-11-19 Iniziato Morgan Stanley Overweight
Mostra tutto

Cabaletta Bio Inc Borsa (CABA) Ultime notizie

pulisher
05:29 AM

How Resilient Is Occidental Petroleum Corporation Stock During Economic Downturns3x Return Stock Radar - Newser

05:29 AM
pulisher
Jul 25, 2025

What drives Cabaletta Bio Inc. stock priceRapid market gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Why Cabaletta Bio Inc. stock is on top investor watchlistsSkyrocketing returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Cabaletta Bio Inc. stockHigh-yield capital appreciation - Autocar Professional

Jul 25, 2025
pulisher
Jul 22, 2025

Cabaletta Bio Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Cabaletta Bio Inc. stock attracts strong analyst attentionFree Best Performing Stock Alerts - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Will Cabaletta Bio Inc. stock benefit from interest rate changesPredictable High Return Trades - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Is Cabaletta Bio Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Cabaletta Bio’s RESET-SLE Study: A Promising Step in Lupus Treatment - TipRanks

Jul 21, 2025
pulisher
Jul 19, 2025

Cabaletta Bio’s RESET-MG Study: A Potential Game-Changer for Myasthenia Gravis Treatment - The Globe and Mail

Jul 19, 2025
pulisher
Jul 18, 2025

What institutions are buying Cabaletta Bio Inc. stock nowFree Predictions - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Cabaletta Bio’s RESET-Myositis Study: A Promising Step in Autoimmune Treatment - TipRanks

Jul 17, 2025
pulisher
Jul 16, 2025

Cabaletta Bio’s RESET-MG Study: A Promising Step in Myasthenia Gravis Treatment - TipRanks

Jul 16, 2025
pulisher
Jul 15, 2025

How Cabaletta Bio Inc. stock performs during market volatilityFree Wealth-Building Investment Strategies - beatles.ru

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Cabaletta Bio Inc. stock price move sharplyCapital Growth Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Cabaletta Bio’s RESET-Myositis Study: A Potential Game-Changer in Autoimmune Disease Treatment - TipRanks

Jul 15, 2025
pulisher
Jul 13, 2025

Cabaletta Bio (NASDAQ:CABA) Stock Price Up 1.3%Here's What Happened - MarketBeat

Jul 13, 2025
pulisher
Jul 12, 2025

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jul 12, 2025
pulisher
Jul 12, 2025

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Jul 12, 2025
pulisher
Jun 30, 2025

Cabaletta Bio, Inc.(NasdaqGS: CABA) dropped from Russell 2000 Dynamic Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Cabaletta Bio, Inc.(NasdaqGS: CABA) dropped from Russell Microcap Growth Index - MarketScreener

Jun 30, 2025

Cabaletta Bio Inc Azioni (CABA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):